Global In Vitro Diagnostics (IVD) Quality Control Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 127
Published Date: 30 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global In Vitro Diagnostics (IVD) Quality Control market size was valued at USD 807.8 million in 2023 and is forecast to a readjusted size of USD 974.3 million by 2030 with a CAGR of 2.7% during review period.
Related products that used to control quality of In Vitro Diagnostics.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the In Vitro Diagnostics (IVD) Quality Control industry chain, the market status of Clinical Chemistry (Quality Controls, Data Management), Immunochemistry (Quality Controls, Data Management), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of In Vitro Diagnostics (IVD) Quality Control.
Regionally, the report analyzes the In Vitro Diagnostics (IVD) Quality Control markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global In Vitro Diagnostics (IVD) Quality Control market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the In Vitro Diagnostics (IVD) Quality Control market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the In Vitro Diagnostics (IVD) Quality Control industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Quality Controls, Data Management).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the In Vitro Diagnostics (IVD) Quality Control market.
Regional Analysis: The report involves examining the In Vitro Diagnostics (IVD) Quality Control market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the In Vitro Diagnostics (IVD) Quality Control market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to In Vitro Diagnostics (IVD) Quality Control:
Company Analysis: Report covers individual In Vitro Diagnostics (IVD) Quality Control players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards In Vitro Diagnostics (IVD) Quality Control This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Chemistry, Immunochemistry).
Technology Analysis: Report covers specific technologies relevant to In Vitro Diagnostics (IVD) Quality Control. It assesses the current state, advancements, and potential future developments in In Vitro Diagnostics (IVD) Quality Control areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the In Vitro Diagnostics (IVD) Quality Control market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
In Vitro Diagnostics (IVD) Quality Control market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Quality Controls
Data Management
Quality Assurance Services
Market segment by Application
Clinical Chemistry
Immunochemistry
Hematology
Molecular Diagnostics
Coagulation
Microbiology
Others
Market segment by players, this report covers
Siemens Healthcare GmbH
Roche Diagnostics
Abbott
Abbott Laboratories Inc.
Bio-Techne
Hologic Inc.
Qiagen N.V.
Bio-Rad Laboratories Inc.
Quidel Corporation
Becton
Dickinson and Company(BD)
BioMerieux Inc.
Sysmex Corporation
Sero AS
Thermo Fisher Scientific Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In Vitro Diagnostics (IVD) Quality Control product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In Vitro Diagnostics (IVD) Quality Control, with revenue, gross margin and global market share of In Vitro Diagnostics (IVD) Quality Control from 2019 to 2024.
Chapter 3, the In Vitro Diagnostics (IVD) Quality Control competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and In Vitro Diagnostics (IVD) Quality Control market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In Vitro Diagnostics (IVD) Quality Control.
Chapter 13, to describe In Vitro Diagnostics (IVD) Quality Control research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of In Vitro Diagnostics (IVD) Quality Control
1.2 Market Estimation Caveats and Base Year
1.3 Classification of In Vitro Diagnostics (IVD) Quality Control by Type
1.3.1 Overview: Global In Vitro Diagnostics (IVD) Quality Control Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type in 2023
1.3.3 Quality Controls
1.3.4 Data Management
1.3.5 Quality Assurance Services
1.4 Global In Vitro Diagnostics (IVD) Quality Control Market by Application
1.4.1 Overview: Global In Vitro Diagnostics (IVD) Quality Control Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical Chemistry
1.4.3 Immunochemistry
1.4.4 Hematology
1.4.5 Molecular Diagnostics
1.4.6 Coagulation
1.4.7 Microbiology
1.4.8 Others
1.5 Global In Vitro Diagnostics (IVD) Quality Control Market Size & Forecast
1.6 Global In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast by Region
1.6.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global In Vitro Diagnostics (IVD) Quality Control Market Size by Region, (2019-2030)
1.6.3 North America In Vitro Diagnostics (IVD) Quality Control Market Size and Prospect (2019-2030)
1.6.4 Europe In Vitro Diagnostics (IVD) Quality Control Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Size and Prospect (2019-2030)
1.6.6 South America In Vitro Diagnostics (IVD) Quality Control Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Market Size and Prospect (2019-2030)
2.1 Siemens Healthcare GmbH
2.1.1 Siemens Healthcare GmbH Details
2.1.2 Siemens Healthcare GmbH Major Business
2.1.3 Siemens Healthcare GmbH In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.1.4 Siemens Healthcare GmbH In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Siemens Healthcare GmbH Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.2.4 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.3.4 Abbott In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Abbott Laboratories Inc.
2.4.1 Abbott Laboratories Inc. Details
2.4.2 Abbott Laboratories Inc. Major Business
2.4.3 Abbott Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.4.4 Abbott Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Abbott Laboratories Inc. Recent Developments and Future Plans
2.5 Bio-Techne
2.5.1 Bio-Techne Details
2.5.2 Bio-Techne Major Business
2.5.3 Bio-Techne In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.5.4 Bio-Techne In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bio-Techne Recent Developments and Future Plans
2.6 Hologic Inc.
2.6.1 Hologic Inc. Details
2.6.2 Hologic Inc. Major Business
2.6.3 Hologic Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.6.4 Hologic Inc. In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hologic Inc. Recent Developments and Future Plans
2.7 Qiagen N.V.
2.7.1 Qiagen N.V. Details
2.7.2 Qiagen N.V. Major Business
2.7.3 Qiagen N.V. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.7.4 Qiagen N.V. In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qiagen N.V. Recent Developments and Future Plans
2.8 Bio-Rad Laboratories Inc.
2.8.1 Bio-Rad Laboratories Inc. Details
2.8.2 Bio-Rad Laboratories Inc. Major Business
2.8.3 Bio-Rad Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.8.4 Bio-Rad Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Rad Laboratories Inc. Recent Developments and Future Plans
2.9 Quidel Corporation
2.9.1 Quidel Corporation Details
2.9.2 Quidel Corporation Major Business
2.9.3 Quidel Corporation In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.9.4 Quidel Corporation In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Quidel Corporation Recent Developments and Future Plans
2.10 Becton
2.10.1 Becton Details
2.10.2 Becton Major Business
2.10.3 Becton In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.10.4 Becton In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Becton Recent Developments and Future Plans
2.11 Dickinson and Company(BD)
2.11.1 Dickinson and Company(BD) Details
2.11.2 Dickinson and Company(BD) Major Business
2.11.3 Dickinson and Company(BD) In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.11.4 Dickinson and Company(BD) In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dickinson and Company(BD) Recent Developments and Future Plans
2.12 BioMerieux Inc.
2.12.1 BioMerieux Inc. Details
2.12.2 BioMerieux Inc. Major Business
2.12.3 BioMerieux Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.12.4 BioMerieux Inc. In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 BioMerieux Inc. Recent Developments and Future Plans
2.13 Sysmex Corporation
2.13.1 Sysmex Corporation Details
2.13.2 Sysmex Corporation Major Business
2.13.3 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.13.4 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sysmex Corporation Recent Developments and Future Plans
2.14 Sero AS
2.14.1 Sero AS Details
2.14.2 Sero AS Major Business
2.14.3 Sero AS In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.14.4 Sero AS In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Sero AS Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. In Vitro Diagnostics (IVD) Quality Control Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3.1 Global In Vitro Diagnostics (IVD) Quality Control Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of In Vitro Diagnostics (IVD) Quality Control by Company Revenue
3.2.2 Top 3 In Vitro Diagnostics (IVD) Quality Control Players Market Share in 2023
3.2.3 Top 6 In Vitro Diagnostics (IVD) Quality Control Players Market Share in 2023
3.3 In Vitro Diagnostics (IVD) Quality Control Market: Overall Company Footprint Analysis
3.3.1 In Vitro Diagnostics (IVD) Quality Control Market: Region Footprint
3.3.2 In Vitro Diagnostics (IVD) Quality Control Market: Company Product Type Footprint
3.3.3 In Vitro Diagnostics (IVD) Quality Control Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global In Vitro Diagnostics (IVD) Quality Control Consumption Value and Market Share by Type (2019-2024)
4.2 Global In Vitro Diagnostics (IVD) Quality Control Market Forecast by Type (2025-2030)
5.1 Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application (2019-2024)
5.2 Global In Vitro Diagnostics (IVD) Quality Control Market Forecast by Application (2025-2030)
6.1 North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2030)
6.2 North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2030)
6.3 North America In Vitro Diagnostics (IVD) Quality Control Market Size by Country
6.3.1 North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2030)
6.3.2 United States In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
6.3.3 Canada In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
6.3.4 Mexico In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
7.1 Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2030)
7.2 Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2030)
7.3 Europe In Vitro Diagnostics (IVD) Quality Control Market Size by Country
7.3.1 Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2030)
7.3.2 Germany In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
7.3.3 France In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
7.3.4 United Kingdom In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
7.3.5 Russia In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
7.3.6 Italy In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2030)
8.2 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2030)
8.3 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Size by Region
8.3.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Region (2019-2030)
8.3.2 China In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
8.3.3 Japan In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
8.3.4 South Korea In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
8.3.5 India In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
8.3.7 Australia In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
9.1 South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2030)
9.2 South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2030)
9.3 South America In Vitro Diagnostics (IVD) Quality Control Market Size by Country
9.3.1 South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2030)
9.3.2 Brazil In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
9.3.3 Argentina In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2030)
10.2 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2030)
10.3 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Market Size by Country
10.3.1 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2030)
10.3.2 Turkey In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
10.3.4 UAE In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2019-2030)
11.1 In Vitro Diagnostics (IVD) Quality Control Market Drivers
11.2 In Vitro Diagnostics (IVD) Quality Control Market Restraints
11.3 In Vitro Diagnostics (IVD) Quality Control Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 In Vitro Diagnostics (IVD) Quality Control Industry Chain
12.2 In Vitro Diagnostics (IVD) Quality Control Upstream Analysis
12.3 In Vitro Diagnostics (IVD) Quality Control Midstream Analysis
12.4 In Vitro Diagnostics (IVD) Quality Control Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Siemens Healthcare GmbH Company Information, Head Office, and Major Competitors
Table 6. Siemens Healthcare GmbH Major Business
Table 7. Siemens Healthcare GmbH In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 8. Siemens Healthcare GmbH In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Siemens Healthcare GmbH Recent Developments and Future Plans
Table 10. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 13. Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Diagnostics Recent Developments and Future Plans
Table 15. Abbott Company Information, Head Office, and Major Competitors
Table 16. Abbott Major Business
Table 17. Abbott In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 18. Abbott In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Recent Developments and Future Plans
Table 20. Abbott Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 21. Abbott Laboratories Inc. Major Business
Table 22. Abbott Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 23. Abbott Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Abbott Laboratories Inc. Recent Developments and Future Plans
Table 25. Bio-Techne Company Information, Head Office, and Major Competitors
Table 26. Bio-Techne Major Business
Table 27. Bio-Techne In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 28. Bio-Techne In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bio-Techne Recent Developments and Future Plans
Table 30. Hologic Inc. Company Information, Head Office, and Major Competitors
Table 31. Hologic Inc. Major Business
Table 32. Hologic Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 33. Hologic Inc. In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Hologic Inc. Recent Developments and Future Plans
Table 35. Qiagen N.V. Company Information, Head Office, and Major Competitors
Table 36. Qiagen N.V. Major Business
Table 37. Qiagen N.V. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 38. Qiagen N.V. In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Qiagen N.V. Recent Developments and Future Plans
Table 40. Bio-Rad Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 41. Bio-Rad Laboratories Inc. Major Business
Table 42. Bio-Rad Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 43. Bio-Rad Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bio-Rad Laboratories Inc. Recent Developments and Future Plans
Table 45. Quidel Corporation Company Information, Head Office, and Major Competitors
Table 46. Quidel Corporation Major Business
Table 47. Quidel Corporation In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 48. Quidel Corporation In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Quidel Corporation Recent Developments and Future Plans
Table 50. Becton Company Information, Head Office, and Major Competitors
Table 51. Becton Major Business
Table 52. Becton In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 53. Becton In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Becton Recent Developments and Future Plans
Table 55. Dickinson and Company(BD) Company Information, Head Office, and Major Competitors
Table 56. Dickinson and Company(BD) Major Business
Table 57. Dickinson and Company(BD) In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 58. Dickinson and Company(BD) In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Dickinson and Company(BD) Recent Developments and Future Plans
Table 60. BioMerieux Inc. Company Information, Head Office, and Major Competitors
Table 61. BioMerieux Inc. Major Business
Table 62. BioMerieux Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 63. BioMerieux Inc. In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. BioMerieux Inc. Recent Developments and Future Plans
Table 65. Sysmex Corporation Company Information, Head Office, and Major Competitors
Table 66. Sysmex Corporation Major Business
Table 67. Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 68. Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Sysmex Corporation Recent Developments and Future Plans
Table 70. Sero AS Company Information, Head Office, and Major Competitors
Table 71. Sero AS Major Business
Table 72. Sero AS In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 73. Sero AS In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Sero AS Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Inc. Major Business
Table 77. Thermo Fisher Scientific Inc. In Vitro Diagnostics (IVD) Quality Control Product and Solutions
Table 78. Thermo Fisher Scientific Inc. In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 80. Global In Vitro Diagnostics (IVD) Quality Control Revenue (USD Million) by Players (2019-2024)
Table 81. Global In Vitro Diagnostics (IVD) Quality Control Revenue Share by Players (2019-2024)
Table 82. Breakdown of In Vitro Diagnostics (IVD) Quality Control by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in In Vitro Diagnostics (IVD) Quality Control, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key In Vitro Diagnostics (IVD) Quality Control Players
Table 85. In Vitro Diagnostics (IVD) Quality Control Market: Company Product Type Footprint
Table 86. In Vitro Diagnostics (IVD) Quality Control Market: Company Product Application Footprint
Table 87. In Vitro Diagnostics (IVD) Quality Control New Market Entrants and Barriers to Market Entry
Table 88. In Vitro Diagnostics (IVD) Quality Control Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Share by Type (2019-2024)
Table 91. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Forecast by Type (2025-2030)
Table 92. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2024)
Table 93. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Forecast by Application (2025-2030)
Table 94. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value by Country (2025-2030) & (USD Million)
Table 124. In Vitro Diagnostics (IVD) Quality Control Raw Material
Table 125. Key Suppliers of In Vitro Diagnostics (IVD) Quality Control Raw Materials
List of Figures
Figure 1. In Vitro Diagnostics (IVD) Quality Control Picture
Figure 2. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type in 2023
Figure 4. Quality Controls
Figure 5. Data Management
Figure 6. Quality Assurance Services
Figure 7. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application in 2023
Figure 9. Clinical Chemistry Picture
Figure 10. Immunochemistry Picture
Figure 11. Hematology Picture
Figure 12. Molecular Diagnostics Picture
Figure 13. Coagulation Picture
Figure 14. Microbiology Picture
Figure 15. Others Picture
Figure 16. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market In Vitro Diagnostics (IVD) Quality Control Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Region (2019-2030)
Figure 20. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Region in 2023
Figure 21. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 24. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 26. Global In Vitro Diagnostics (IVD) Quality Control Revenue Share by Players in 2023
Figure 27. In Vitro Diagnostics (IVD) Quality Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players In Vitro Diagnostics (IVD) Quality Control Market Share in 2023
Figure 29. Global Top 6 Players In Vitro Diagnostics (IVD) Quality Control Market Share in 2023
Figure 30. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Share by Type (2019-2024)
Figure 31. Global In Vitro Diagnostics (IVD) Quality Control Market Share Forecast by Type (2025-2030)
Figure 32. Global In Vitro Diagnostics (IVD) Quality Control Consumption Value Share by Application (2019-2024)
Figure 33. Global In Vitro Diagnostics (IVD) Quality Control Market Share Forecast by Application (2025-2030)
Figure 34. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type (2019-2030)
Figure 35. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application (2019-2030)
Figure 36. North America In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Country (2019-2030)
Figure 37. United States In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 44. France In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Region (2019-2030)
Figure 51. China In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 54. India In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 57. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type (2019-2030)
Figure 58. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application (2019-2030)
Figure 59. South America In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE In Vitro Diagnostics (IVD) Quality Control Consumption Value (2019-2030) & (USD Million)
Figure 68. In Vitro Diagnostics (IVD) Quality Control Market Drivers
Figure 69. In Vitro Diagnostics (IVD) Quality Control Market Restraints
Figure 70. In Vitro Diagnostics (IVD) Quality Control Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of In Vitro Diagnostics (IVD) Quality Control in 2023
Figure 73. Manufacturing Process Analysis of In Vitro Diagnostics (IVD) Quality Control
Figure 74. In Vitro Diagnostics (IVD) Quality Control Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Siemens Healthcare GmbH Roche Diagnostics Abbott Abbott Laboratories Inc. Bio-Techne Hologic Inc. Qiagen N.V. Bio-Rad Laboratories Inc. Quidel Corporation Becton Dickinson and Company(BD) BioMerieux Inc. Sysmex Corporation Sero AS Thermo Fisher Scientific Inc.
Related Reports
24 Feb 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
